Consano Bio, Inc., a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopedic conditions, today announced that the U.S. Food and Drug ...
Consano Bio receives US FDA IND clearance to expand the C-1101 chronic sciatica clinical development programme into US: Burlington, Massachusetts Tuesday, July 21, 2026, 14:00 Hrs ...
LLC "LSR. The Management Company acquired 0.34% of PJSC LSR Group, increasing its share to 2.188% from 1.848%. The change took place on November 2. This is stated in the message of the group. PJSC LSR ...
Drugs designed to treat diabetes and repurposed as miracle diet aids have taken over TikTok - and Hollywood. The weight loss caused by these weekly injectables is rapid and previously unattainable, ...